arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2208.04495stat.MEstat.AP
收藏

使用协变量调整伪值回归的限制平均生存时间估计以提升精度

Restricted mean survival time estimate using covariate adjusted pseudovalue regression to improve precision

Yunfan Li, Jessica L. Ross, Aaron M. Smith, David P. Miller

AI总结:

针对事件时间分析中协变量调整的难题,提出基于协变量调整伪值回归的RMST组间差异估计方法,可提升估计精度、控制I类错误,还能在不损失统计功效的前提下缩小随机研究样本量。

摘要:

随机临床试验的从业者和监管方都期望采用协变量调整,因为它能提升治疗效应估计的精度。然而,在事件时间分析中,协变量调整面临着特殊挑战。我们提出应用协变量调整伪值回归来估计限制平均生存时间(RMST)的组间差异。我们提出的方法纳入预后协变量以提升治疗效应估计的精度,同时维持严格的I类错误控制且不引入偏倚。此外,精度的提升幅度可以被量化,并在研究设计阶段纳入样本量计算。因此,我们提出的方法能够在不损失统计功效的前提下设计规模更小的随机研究。

英文摘要:

Covariate adjustment is desired by both practitioners and regulators of randomized clinical trials because it improves precision for estimating treatment effects. However, covariate adjustment presents a particular challenge in time-to-event analysis. We propose to apply covariate adjusted pseudovalue regression to estimate between-treatment difference in restricted mean survival times (RMST). Our proposed method incorporates a prognostic covariate to increase precision of treatment effect estimate, maintaining strict type I error control without introducing bias. In addition, the amount of increase in precision can be quantified and taken into account in sample size calculation at the study design stage. Consequently, our proposed method provides the ability to design smaller randomized studies at no expense to statistical power.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑